Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Cardlytics Expects Q2 Revenue Of $73M-$81M, Est $81.393M

Author: Benzinga Newsdesk | May 08, 2024 06:35pm

Billings of $115.0 million - $126.0 million, Adjusted EBITDA ($3.0) million - $1.0 million

Posted In: CDLX